Neogenomics, Inc.
NEO
$8.75
$0.091.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -99.21M | -108.03M | -113.47M | -104.04M | -77.59M |
| Total Depreciation and Amortization | 66.51M | 67.82M | 69.62M | 71.17M | 72.01M |
| Total Amortization of Deferred Charges | 1.26M | 1.26M | 1.61M | 1.96M | 2.19M |
| Total Other Non-Cash Items | 74.91M | 76.26M | 76.45M | 67.78M | 45.77M |
| Change in Net Operating Assets | -21.06M | -32.10M | -20.53M | -22.81M | -34.76M |
| Cash from Operations | 22.42M | 5.23M | 13.69M | 14.05M | 7.61M |
| Capital Expenditure | -27.51M | -27.01M | -30.74M | -33.22M | -39.98M |
| Sale of Property, Plant, and Equipment | 2.07M | 2.07M | -- | -- | -- |
| Cash Acquisitions | -6.45M | -6.45M | -6.45M | -5.99M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.00M | 19.06M | 25.69M | 24.48M | 41.87M |
| Cash from Investing | -20.90M | -12.34M | -11.50M | -14.74M | 1.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -201.25M | -201.25M | -201.25M | -201.25M | -- |
| Issuance of Common Stock | 962.00K | 1.91M | 5.02M | 5.67M | 7.63M |
| Repurchase of Common Stock | -949.00K | -949.00K | -949.00K | -949.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -338.00K | 0.00 | -2.86M | -3.09M | -2.86M |
| Cash from Financing | -201.58M | -200.29M | -200.03M | -199.62M | 4.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -32.00K | -54.00K | -- |
| Net Change in Cash | -200.05M | -207.39M | -197.88M | -200.36M | 14.28M |